Full Length Research Paper
References
| Abolfotouh MA, Soliman LA, Mansour E, Faraghaly M, El-Dawaiaty AA (2008). Central obesity among adults in Egypt: Prevalence and associated morbidity. East. Mediterr. Health J. 14. | ||||
|
Akiyamaab T, Tachibanaab I, Shiroharaab H, Watanabeab N, Otsuki M (1996). High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Res. Clin. Pract. 31(1):27-35. crossref |
||||
|
Balcioglu A, Wurtman RJ (2000). Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid. Neuropharmacology 39(12):2352-2359. crossref |
||||
|
Barber T, Vina JR, Vina J, Cabo J (1985). Decreased urea synthesis in cafeteria-diet-induced obesity in the rat. Biochem. J. 230:675-681. Pubmed |
||||
|
Brown M, Bing C, King P, Pickavance L, Heal D, Wilding J (2001). Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male wistar rats independently of hypothalamic neuropeptide Y. Br. J. Pharmacol. 132:1898-1904. crossref |
||||
|
Chaw CS, Yazaki E, Evans DF (2001). The effect of pH on the gastric emptying of liquids measured by electrical impedance tomography and pH-sensitive radiotelemetry capsule. Int. J. Pharm. 227:167–175. crossref |
||||
|
Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard F (2008). Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine 15(10):783-792. crossref |
||||
|
Estornell E, Barber T, Cabo J (1994). Improved nitrogen metabolism in rats fed on lipid-rich liquid diets. Br. J. Nutr. 71:361-373. crossref |
||||
|
Florentin M, Liberopulos EN, Elisaf MS (2007). Sibutramine-associated adverse effects: a practical guide for its safe use. Obes. Rev. 9(4):378-387. crossref |
||||
|
Fujioka K, Greenway F, Sheard J, Ying Y (2006). The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J. Med. Food 9(1):49-54. crossref |
||||
|
Gorinstein S, Caspi A, Libman I, Lerner H T, Huang D, Leontowicz H, Leontowicz M, Tashma Z, Katrich E, Feng S, Trakhtenberg S (2006). Red Grapefruit Positively Influences Serum Triglyceride Level in Patients Suffering from Coronary Atherosclerosis: Studies in Vitro and in Humans. J. Agric. Food Chem.54 (5):1887-1892. crossref |
||||
|
Hamilton BS, Doods HN (2002). Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes. Res. 10(3):182-187. crossref |
||||
| Hodgson RW (1967). Horticultural varieties of Citrus. In: Reuter W, Webber HJ, Batchelor LD (eds.), The Citrus Industry. History, World Distribution, Botany and Varieties, Vol. I. University of California Press. pp. 431-591. | ||||
|
Hossain P, Kawar B, El Nahas M (2007). Obesity and Diabetes in the Developing World— A Growing Challenge. N. Engl. J. Med. 356(3):213-215. crossref |
||||
|
Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ (1997). Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br. J. Pharmacol. 121(8):1613-1618. crossref |
||||
|
Kim SH, Lee YM, Jee SH, Nam CM (2003). Effect of Sibutramine on Weight Loss and Blood Pressure: A Meta-analysis of Controlled Trials. Obes. Res. 11:1116–1123. crossref |
||||
|
Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008). Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47(4)1363-1370. crossref |
||||
|
Kuhlmann J, Neumann-Haefelin C, Belz U, Kramer W, Juretschke HP, Herling AW (2005). Correlation between insulin resistance and intramyocellular lipid levels in rats. Magn. Res. Med. 53(6):1275–1282. crossref |
||||
| Marchesini G, Centis E, Nuccitelli C (2009). The effect of life time changes in the treatment of NAFLD. Poster presentation at Liver and metabolic syndrome. Falk Liver Conference (Part II), Hannover, Germany. | ||||
|
Martire SI, Holmes N, Westbrook RF, Morris MJ (2013). Altered feeding patterns in rats exposed to a palatable cafeteria diet: increased snacking and its implications for development of obesity. PloS one 8(4):e60407. crossref |
||||
|
Murase T, Misawa K, Haramizu S, Minegishi Y, Hase T (2010). Nootkatone, a characteristic constituent of grapefruit, stimulates energy metabolism and prevents diet-induced obesity by activating AMPK. Am. J. Physiol. Endocrinol. Metab. 299(2):E266-E275. crossref |
||||
|
Pagel P, Blome J, Wolf HU (2000). High-performance liquid chromatographic separation and measurements of various biogenic compounds possibly involved in the pathomechanism of Parkinson's disease. J. Chromatography B. 746:297-304. crossref |
||||
| Paget GE, Barnes JM (1964). Evaluation of Drug Activities. In: Lawrence DR, Bacharach AL (Eds.), Pharmacometrics Vol. 1. Academic Press. | ||||
|
Pi-Sunyer FX (2002). The Obesity Epidemic: Pathophysiology and Consequences of Obesity. Obesity Res. 10(suppl.2):S97-S104. crossref |
||||
| Reaven GMD, Strom TK, Fox B (2002). Syndrome X: Overcoming the Silent Killer that Can Give You a Heart Attack. Published by Simon and Schuster, New York. | ||||
|
Robinson D, Whitehead TP (1989). Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann. Clin. Biochem. 26:393-400. crossref |
||||
|
Rodríguez E, Monjo M, Rodríguez-Cuenca S, Pujol E, Amengual B, Roca P, Palou A (2001). Sexual dimorphism in the adrenergic control of rat brown adipose tissue response to overfeeding. Pflugers Arch. Eur. J. Phys. 442(3):396-403. crossref |
||||
|
Rodríguez E, Ribot J, Rodríguez AM, Palou A (2004). PPAR- 2 Expression in Response to Cafeteria Diet: Gender- and Depot-Specific Effects. Obes. Res. 12:1455–1463. crossref |
||||
| Sadhu GV (2010). Process for the preparation of Caralluma extract and a formulation prepared thereof. US Patent App. 12/696,518. | ||||
|
Scora RW, Kumamot J, Soost RK, Nauer EM (1982). Contribution to the origin of the grapefruit Citrus paradisi (Rutaceae). Syst. Bot. 7(2):170-177. crossref |
||||
|
Shela G, Hanna L, Maria L, Ryszard K, Mikolaj G, Zenon J, Yong-Seo P, Soon-Teck J, Seong-Gook K, Simon T (2007). Effect of hesperidin and naringin on the plasma lipid profile and plasma antioxidant activity in rats fed a cholesterol-containing diet. J. Sci. Food Agric. 87(7):1257-1262. crossref |
||||
|
Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, The T, House CM, Fernandez CS, Cox T, Witters LA, Kemp BE (1996). Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271(2):611-614. crossref |
||||
|
Stump AL, Mayo T, Blum A (2006). Management of grapefruit-drug interactions. Am. Fam. Physician 74(4):605-608. Pubmed |
||||
|
Thomson DM, Porter BB, Tall JH, Kim HJ, Barrow JR, Winder WW (2007). Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am. J. Physiol. Endocrinol. Metab. 292(1):E196-202. crossref |
||||
|
Yanovski SZ, Yanovski A (2002). Drug therapy: obesity. N. Engl. J. Med. 346(8):591-602. crossref |
||||
|
Wang JB, Patterson RE, Ang A, Emond J A, Shetty N, Arab L (2014). Timing of energy intake during the day is associated with the risk of obesity in adults. J. Hum. Nutr. Diet 27(s2):255-262. crossref |
||||
|
Wellman PJ (2000). Norepinephrine and the control of food intake. Nutrition 16(10):837-842. crossref |
||||
|
Wilding JPH (2011). Pathophysiology and aetiology of obesity. Medicine 39(1):6-10. crossref |
||||
|
Winder WW, Hardie DG (1999). AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277(1 Pt. 1):E1-10. Pubmed |
||||
|
Winder WW, Hardie DG (1996). Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 270(2 Pt. 1):E299-304. Pubmed |
||||
| World Health Organization (WHO), (2003). Obesity and overweight. Global strategy on diet, physical activity and health. | ||||
| World Health Organization (WHO), (2010). 10 facts on obesity. Available at: http://www.who.int/features/factfiles/obesity/facts/en/index1.html. | ||||
| World Health Organization (WHO), (2011). Obesity and overweight: fact sheet No 311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
